Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors.
Hou F, Yao Y, Wei Y, Wang Y, Cao Y, Liu X, Zheng L, Zhang Q, Jiao Y, Chen Y, Meng Y, Sun Y, Wu Y, Wang J, Wang J, Wu Z, Zhang K, Wei M, Yang G.
Hou F, et al. Among authors: wang j, wang y.
Bioorg Med Chem. 2023 Aug 15;91:117404. doi: 10.1016/j.bmc.2023.117404. Epub 2023 Jul 3.
Bioorg Med Chem. 2023.
PMID: 37429211